Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02639325 : Tumor Related Epilepsy
PhaseN/A
AgesMin: 8 Years Max: N/A
Eligibility
- INCLUSION CRITERIA:

To be eligible for entry into the study, a candidate must meet all the following criteria:

- Be 8 years of age or older.

- Have solitary primary or recurrent brain tumor with associated seizures. Brain tumor
may be diagnosed radiologically. Associated seizures are defined as those with
activity starting within three months of radiologic diagnosis of the primary or
recurrent tumor. In cases when the timing of seizure activity is unclear with respect
to the timing of diagnosis, seizures will be considered associated with the tumor if
seizure semiology is consistent with that location. Ongoing seizures are not required.
Patients can be included if they have had a single previous seizure. Patients who have
not experienced seizures after institution of anti-convulsant therapy are not
excluded.

- Agree to undergo brain surgery.

- Willing and able to appoint a durable power of attorney.

EXCLUSION CRITERIA:

Candidates will be excluded if they:

- Have a bleeding disorder that cannot be corrected before invasive testing or surgery,
or other medical conditions that would make surgery unsafe, such as lung or cardiac
disease that would render them unable to tolerate the risk of general anesthesia, or
severe immunodeficiency or systemic cancer not related to a brain lesion.

- Cannot have an MRI scan.

- Have multiple brain tumors, evidence of carcinomatous meningitis, gliomatosis cerebri,
or primary CNS lymphoma. Patients with multiple metastatic lesions that for which
surgery is not indicated will be exluded. Patients with peripheral neurological or
systemic metabolic disorders that cause seizures will be excluded.

- Have an underlying seizure disorder that is unrelated to the brain tumor, or
underlying neurological disorder that is unrelated to the brain tumor and that may
contribute to seizure activity.

- At the time of enrollment, lack consent capacity due to cognitive impairment that
would make them incapable of understanding the explanation of the procedures in this
study. Cognitive capacity to consent will be determined at the time of enrollment.
Patients with mental disorders or those patients who are cognitively impaired yet
still retain consent capacity will not be excluded. Children may be enrolled if there
is a parent or guardian able to consent on their behalf.
LinksPermanent Link to THIS page: http://virtualtrials.com/nct/display1trial.cfm?nct=NCT02639325      |      Link to official Clinicaltrials.gov listing
Locations
Bethesda, Maryland
Facility: National Institutes of Health Clinical Center, 9000 Rockville Pike
Investigator:
Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) Phone: 800-411-1222
Click HERE to send email to this center




Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites